Skip to Content
Merck
CN
HomeThe Formulation Box - Biomolecules Stabilization and Aggregation Prevention

The Formulation Box - Biomolecules Stabilization and Aggregation Prevention

You are cordially invited to discover in 4 steps how you can improve your strategies for biomolecules formulation development and extend your knowledge about viscosity reduction capabilities.

You will explore solutions how to:

  • Mitigate the strong constraints of biomolecules formulations categorized as high-risk applications.
  • Preserve and maintain biomolecules stability and efficacy along the downstream purification process.
  • Balance stability and viscosity challenges with highly concentrated Antibody solutions.


Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?